Cargando…

Targeted exome analysis of Russian patients with hypertrophic cardiomyopathy

BACKGROUND: Hypertrophic cardiomyopathy (HCM), described as the presence of hypertrophy of left ventricular, is the most prevalent heritable cardiovascular disease with predominantly an autosomal dominant type of inheritance. However, pathogenic alleles are not identified in at least 25% of patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Filatova, Elena V., Krylova, Natalia S., Vlasov, Ivan N., Maslova, Maria S., Poteshkina, Natalia G., Slominsky, Petr A., Shadrina, Maria I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8606207/
https://www.ncbi.nlm.nih.gov/pubmed/34598319
http://dx.doi.org/10.1002/mgg3.1808
_version_ 1784602296005427200
author Filatova, Elena V.
Krylova, Natalia S.
Vlasov, Ivan N.
Maslova, Maria S.
Poteshkina, Natalia G.
Slominsky, Petr A.
Shadrina, Maria I.
author_facet Filatova, Elena V.
Krylova, Natalia S.
Vlasov, Ivan N.
Maslova, Maria S.
Poteshkina, Natalia G.
Slominsky, Petr A.
Shadrina, Maria I.
author_sort Filatova, Elena V.
collection PubMed
description BACKGROUND: Hypertrophic cardiomyopathy (HCM), described as the presence of hypertrophy of left ventricular, is the most prevalent heritable cardiovascular disease with predominantly an autosomal dominant type of inheritance. However, pathogenic alleles are not identified in at least 25% of patients with HCM, and the spectrum of pathogenic variants that contribute to the development of HCM in Russia has not been fully described. Therefore, the goal of our study was to identify genetic variants associated with the etiopathogenesis of HCM in Russian patients. METHODS: The study cohort included 98 unrelated adult patients with HCM. We performed targeted exome sequencing, an analysis using various algorithms for prediction of the impact of variants on protein structure and the prediction of pathogenicity using ACMG Guidelines. RESULTS: The frequency of pathogenic and likely pathogenic variants in all HCM‐related genes was 8% in our patients. We also identified 20 variants of uncertain significance in all HCM‐related genes. CONCLUSIONS: The prevalence of individual pathogenic variants in HCM‐related genes in Russian population appears to be lower than in general European population, which could be explained by ethnic features of Russian population, age characteristics of our sample, or unidentified pathogenic variants in genes previously not linked with HCM.
format Online
Article
Text
id pubmed-8606207
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-86062072021-11-29 Targeted exome analysis of Russian patients with hypertrophic cardiomyopathy Filatova, Elena V. Krylova, Natalia S. Vlasov, Ivan N. Maslova, Maria S. Poteshkina, Natalia G. Slominsky, Petr A. Shadrina, Maria I. Mol Genet Genomic Med Original Articles BACKGROUND: Hypertrophic cardiomyopathy (HCM), described as the presence of hypertrophy of left ventricular, is the most prevalent heritable cardiovascular disease with predominantly an autosomal dominant type of inheritance. However, pathogenic alleles are not identified in at least 25% of patients with HCM, and the spectrum of pathogenic variants that contribute to the development of HCM in Russia has not been fully described. Therefore, the goal of our study was to identify genetic variants associated with the etiopathogenesis of HCM in Russian patients. METHODS: The study cohort included 98 unrelated adult patients with HCM. We performed targeted exome sequencing, an analysis using various algorithms for prediction of the impact of variants on protein structure and the prediction of pathogenicity using ACMG Guidelines. RESULTS: The frequency of pathogenic and likely pathogenic variants in all HCM‐related genes was 8% in our patients. We also identified 20 variants of uncertain significance in all HCM‐related genes. CONCLUSIONS: The prevalence of individual pathogenic variants in HCM‐related genes in Russian population appears to be lower than in general European population, which could be explained by ethnic features of Russian population, age characteristics of our sample, or unidentified pathogenic variants in genes previously not linked with HCM. John Wiley and Sons Inc. 2021-10-01 /pmc/articles/PMC8606207/ /pubmed/34598319 http://dx.doi.org/10.1002/mgg3.1808 Text en © 2021 Institute of Molecular Genetics of National Research Centre Kurchatov Institute. Molecular Genetics & Genomic Medicine published by Wiley Periodicals LLC. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Articles
Filatova, Elena V.
Krylova, Natalia S.
Vlasov, Ivan N.
Maslova, Maria S.
Poteshkina, Natalia G.
Slominsky, Petr A.
Shadrina, Maria I.
Targeted exome analysis of Russian patients with hypertrophic cardiomyopathy
title Targeted exome analysis of Russian patients with hypertrophic cardiomyopathy
title_full Targeted exome analysis of Russian patients with hypertrophic cardiomyopathy
title_fullStr Targeted exome analysis of Russian patients with hypertrophic cardiomyopathy
title_full_unstemmed Targeted exome analysis of Russian patients with hypertrophic cardiomyopathy
title_short Targeted exome analysis of Russian patients with hypertrophic cardiomyopathy
title_sort targeted exome analysis of russian patients with hypertrophic cardiomyopathy
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8606207/
https://www.ncbi.nlm.nih.gov/pubmed/34598319
http://dx.doi.org/10.1002/mgg3.1808
work_keys_str_mv AT filatovaelenav targetedexomeanalysisofrussianpatientswithhypertrophiccardiomyopathy
AT krylovanatalias targetedexomeanalysisofrussianpatientswithhypertrophiccardiomyopathy
AT vlasovivann targetedexomeanalysisofrussianpatientswithhypertrophiccardiomyopathy
AT maslovamarias targetedexomeanalysisofrussianpatientswithhypertrophiccardiomyopathy
AT poteshkinanataliag targetedexomeanalysisofrussianpatientswithhypertrophiccardiomyopathy
AT slominskypetra targetedexomeanalysisofrussianpatientswithhypertrophiccardiomyopathy
AT shadrinamariai targetedexomeanalysisofrussianpatientswithhypertrophiccardiomyopathy